Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Colton Strong"'
Autor:
Shivshankari Rajkumar, Diana Berry, Kayla A. Heney, Colton Strong, LeeAnn Ramsay, Mathieu Lajoie, Rached Alkallas, Tan-Trieu Nguyen, Cameron Thomson, Mozhdeh Ahanfeshar-Adams, Matthew Dankner, Teresa Petrella, April A.N. Rose, Peter M. Siegel, Ian R. Watson
Publikováno v:
Cell Reports, Vol 39, Iss 1, Pp 110634- (2022)
Summary: Although combination BRAF/MEK inhibition has produced significant survival benefits for BRAF p.V600 mutant melanomas, targeted therapies approved for BRAF non-p.V600 mutant melanomas remain limited. Through the analysis of 772 cutaneous mela
Externí odkaz:
https://doaj.org/article/640812e1a89846ff8e8c5f518bbb3180
Autor:
Miffy Hok Yan Cheng, Jerry Leung, Yao Zhang, Colton Strong, Genc Basha, Arash Momeni, Yihang Chen, Eric Jan, Amir Abdolahzadeh, Xinying Wang, Jayesh A. Kulkarni, Dominik Witzigmann, Pieter R. Cullis
Publikováno v:
Advanced Materials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd2f3f0e0ad235f7c9054f85e3c94bfd
https://doi.org/10.1002/adma.202303370
https://doi.org/10.1002/adma.202303370
Autor:
Shivshankari Rajkumar, Diana Berry, Kayla A. Heney, Colton Strong, LeeAnn Ramsay, Mathieu Lajoie, Rached Alkallas, Tan-Trieu Nguyen, Cameron Thomson, Mozhdeh Ahanfeshar-Adams, Matthew Dankner, Teresa Petrella, April A.N. Rose, Peter M. Siegel, Ian R. Watson
Publikováno v:
Cell reports. 39(1)
Although combination BRAF/MEK inhibition has produced significant survival benefits for BRAF p.V600 mutant melanomas, targeted therapies approved for BRAF non-p.V600 mutant melanomas remain limited. Through the analysis of 772 cutaneous melanoma exom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d92cafa7a32e1bf669270cfaf6b133f1
https://pubmed.ncbi.nlm.nih.gov/35385748
https://pubmed.ncbi.nlm.nih.gov/35385748